Literature DB >> 11337356

Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas.

J Kamarashev1, G Burg, M C Mingari, W Kempf, G Hofbauer, R Dummer.   

Abstract

Cutaneous lymphomas of the cytotoxic phenotype, including CD8+ and CD56+ lymphomas, have only recently been recognized. To characterize the phenotypic profile of these lymphomas, we investigated the expression of both cytotoxic molecules and killer cell inhibitory receptors by immunohistochemistry techniques. Frozen sections from four CD8+ and from three CD56+ cutaneous lymphomas were stained for the cytotoxicity markers including T-cell restricted intracellular antigen-1, perforin, granzyme B, and for expression of the inhibitory receptors including p58.1, p58.2, p70, p140, CD94, NKG2, and leukocyte immunoglobulin-like receptor (LIR-1). Apart from LIR-1, the CD8+ lymphomas in our series express p70 and p140 from the inhibitory receptors and only one or two of the cytotoxic proteins. The CD56+ lymphomas, on the other hand, express only LIR-1 of the set of inhibitory receptors and the whole panel of cytotoxic antigens. Various subtypes of cytotoxic cutaneous lymphomas (CD8+ and CD56+) differ in regard to their phenotypic and functional profile, which may explain differences in their biological behavior.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337356      PMCID: PMC1891966          DOI: 10.1016/S0002-9440(10)64114-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.

Authors:  E Berti; D Tomasini; M H Vermeer; C J Meijer; E Alessi; R Willemze
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  In search of the 'missing self': MHC molecules and NK cell recognition.

Authors:  H G Ljunggren; K Kärre
Journal:  Immunol Today       Date:  1990-07

3.  A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells.

Authors:  Q Tian; M Streuli; H Saito; S F Schlossman; P Anderson
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

Review 4.  Killer cell inhibitory receptors: diversity, specificity, and function.

Authors:  E O Long; D N Burshtyn; W P Clark; M Peruzzi; S Rajagopalan; S Rojo; N Wagtmann; C C Winter
Journal:  Immunol Rev       Date:  1997-02       Impact factor: 12.988

Review 5.  Perforin: structure and function.

Authors:  C C Liu; C M Walsh; J D Young
Journal:  Immunol Today       Date:  1995-04

6.  Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.

Authors:  M Colonna; J Samaridis
Journal:  Science       Date:  1995-04-21       Impact factor: 47.728

7.  Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes.

Authors:  B A Agnarsson; E C Vonderheid; M E Kadin
Journal:  J Am Acad Dermatol       Date:  1990-04       Impact factor: 11.527

8.  High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma.

Authors:  M Adachi; K Maeda; M Takekawa; Y Hinoda; K Imai; S Sugiyama; A Yachi
Journal:  Am J Hematol       Date:  1994-12       Impact factor: 10.047

9.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.

Authors:  A Moretta; S Sivori; M Vitale; D Pende; L Morelli; R Augugliaro; C Bottino; L Moretta
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

10.  The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.

Authors:  J E Gumperz; V Litwin; J H Phillips; L L Lanier; P Parham
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  1 in total

1.  The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies.

Authors:  Konstantinos Liapis; Andrew Clear; Andrew Owen; Rita Coutinho; Paul Greaves; Abigail M Lee; Silvia Montoto; Maria Calaminici; John G Gribben
Journal:  Blood       Date:  2013-05-07       Impact factor: 22.113

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.